RIGEL PHARMACEUTICALS, INC. (RIGL) Gross margin 2018–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) gross margin by fiscal year — reported gross profit divided by reported revenue.
93.3%FY2025 · since FY2018: 99.4% → 93.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 93.3% | +3.7 pp |
| FY2024 | 89.6% | -4.3 pp |
| FY2023 | 93.9% | -4.6 pp |
| FY2022 | 98.5% | -0.7 pp |
| FY2021 | 99.3% | +0.1 pp |
| FY2020 | 99.2% | +0.7 pp |
| FY2019 | 98.5% | -0.9 pp |
| FY2018 | 99.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net incomeRIGL Net marginRIGL Gross profitRIGL Operating incomeRIGL Operating marginRIGL Operating cash flowRIGL Free cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total assetsRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →